Bromocriptine shifts the blood pressure circadian rhythm in type 2 DM and stage 4 of chronic kidney disease patients: A post hoc study
Oliva Mejía-Rodríguez(Mexican Social Security Institute), Ramón Paniagua, Humberto Ruiz-Vega, María Eugenia Galván-Plata(Mexican Social Security Institute), Guillermo Ceballos(Universidad Marista), Cleto Álvarez-Aguilar
Cited by 0
Related Papers
(–)‐Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle
|The Journal of Physiology|2011|202
Academic student satisfaction and perceived performance in the e-learning environment during the COVID-19 pandemic: Evidence across ten countries
|PLoS ONE|2021|186
Higher education students’ achievement emotions and their antecedents in e-learning amid COVID-19 pandemic: A multi-country survey
|Learning and Instruction|2022|60
Cardiovascular and Renal Effects of Bromocriptine in Diabetic Patients with Stage 4 Chronic Kidney Disease
|BioMed Research International|2013|25